Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 for Hyperuricemia With or Without Gout to Evaluate the Safety and Noninferiority of FYU-981 (Phase III Study)
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Dotinurad (Primary) ; Benzbromarone
- Indications Hyperuricaemia
- Focus Therapeutic Use
- Sponsors Fuji Yakuhin
- 24 Sep 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 07 Sep 2017 Status changed from recruiting to active, no longer recruiting.